HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology4 papers

Linear scleroderma

Last edited: 4/22/2026

Overview

Linear scleroderma is a localized form of scleroderma characterized by thickened, hardened skin in a linear pattern, often affecting children and potentially associated with systemic autoimmune manifestations 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of linear skin induration 1.
  • Recommended Tests:
    • - Complete history and physical examination 1. - Laboratory evaluation for antinuclear antibodies (ANA) and rheumatoid factor (RF) 1.
  • Grading: Not explicitly detailed in provided abstracts 1.

    • Management

  • First-Line Treatments:
    • - No specific drug doses mentioned; symptomatic management and monitoring 1.
  • Adjunctive Treatments:
    • - Consideration of immunosuppressive therapy in cases with systemic involvement, though specific agents and dosing are not detailed 1.

    Special Populations

  • Pediatrics: Juvenile cases often exhibit serologic abnormalities such as ANA and RF; long-term observation is recommended 1.
  • Comorbidities: Patients with serologic abnormalities may be at risk for systemic collagen-vascular diseases like nephritis and Raynaud's phenomenon 1.

    • Key Recommendations

  • Conduct thorough initial evaluations including history, physical exam, and laboratory tests for ANA and RF in patients with linear scleroderma (Evidence: Moderate 1).
  • Implement long-term monitoring with periodic reevaluation for potential systemic complications in pediatric patients (Evidence: Moderate 1).
  • Consider systemic disease risk assessment in patients with positive serologic markers (ANA, RF) for tailored follow-up strategies (Evidence: Expert opinion 1).

    • References

    1 Woo TY, Rasmussen JE. Juvenile linear scleroderma associated with serologic abnormalities. Archives of dermatology 1985. link

    Original source

    1. [1]
      Juvenile linear scleroderma associated with serologic abnormalities. — Woo TY, Rasmussen JE Archives of dermatology (1985)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG